Clinical Research Directory
Browse clinical research sites, groups, and studies.
Dose Ranging Study of ORKA-001 in Patients With Moderate-to-Severe Plaque Psoriasis
Sponsor: Oruka Therapeutics, Inc.
Summary
This is a multicenter, randomized, double-blinded, placebo-controlled, dose-range finding study to evaluate the efficacy and safety of ORKA-001 in adult participants with moderate-to-severe plaque psoriasis.
Official title: A Multicenter, Randomized, Double-blinded, Placebo-controlled, Dose-range Finding Study of ORKA-001 in Participants With Moderate-to-Severe Plaque Psoriasis
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
160
Start Date
2025-12-03
Completion Date
2028-12
Last Updated
2026-03-30
Healthy Volunteers
No
Conditions
Interventions
ORKA-001
ORKA-001 administered by subcutaneous (SC) injection
Placebo
Placebo administered by subcutaneous (SC) injection
Locations (26)
Oruka Therapeutics Investigative Site
Phoenix, Arizona, United States
Oruka Therapeutics Investigative Site
North Little Rock, Arkansas, United States
Oruka Therapeutics Investigative Site
Los Angeles, California, United States
Oruka Therapeutics Investigative Site
Los Angeles, California, United States
Oruka Therapeutics Investigative Site
San Diego, California, United States
Oruka Therapeutics Investigative Site
Coral Gables, Florida, United States
Oruka Therapeutics Investigative Site
Rolling Meadows, Illinois, United States
Oruka Therapeutics Investigative Site
Plainfield, Indiana, United States
Oruka Therapeutics Investigative Site
Rockville, Maryland, United States
Oruka Therapeutics Investigative Site
Kew Gardens, New York, United States
Oruka Therapeutics Investigative Site
Chapel Hill, North Carolina, United States
Oruka Therapeutics Investigative Site
Cleveland, Ohio, United States
Oruka Therapeutics Investigative Site
Mason, Ohio, United States
Oruka Therapeutics Investigative Site
Portland, Oregon, United States
Oruka Therapeutics Investigative Site
Portland, Oregon, United States
Oruka Therapeutics Investigative Site
Philadelphia, Pennsylvania, United States
Oruka Therapeutics Investigative Site
Frisco, Texas, United States
Oruka Therapeutics Investigative Site
Houston, Texas, United States
Oruka Therapeutics Investigative Site
Webster, Texas, United States
Oruka Therapeutics Investigative Site
Norfolk, Virginia, United States
Oruka Therapeutics Investigative Site
Surrey, British Columbia, Canada
Oruka Therapeutics Investigative Site
Fredericton, New Brunswick, Canada
Oruka Therapeutics Investigative Site
Ajax, Ontario, Canada
Oruka Therapeutics Investigative Site
Peterborough, Ontario, Canada
Oruka Therapeutics Investigative Site
Montreal, Quebec, Canada
Oruka Therapeutics Investigative Site
Québec, Quebec, Canada